- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
History of Medical Cannabis in Missouri
In 2014, Missouri passed HB 2238, which created a legal right for eligible patients to obtain, possess, and use hemp extracts in limited circumstances. The law defines a hemp extract as a preparation of cannabis that contains at least 5 percent CBD and no more than 0.3 percent THC, and only allows access to these extracts for patients with severe seizure disorders who have a recommendation from a neurologist and state hemp registration card. Patients are allowed to purchase hemp extracts from two state-regulated “cannabidiol oil care centers”, which were licensed by the Department of Agriculture in 2015 and began serving patients in 2016.
In 2018, Show-Me State voters did just that, approving Amendment 2 and authorizing the creation of a comprehensive medical cannabis framework. The measure allows for home cultivation and personal possession limits of up to four ounces for a 30-day period (no more is allowed without demonstrating a medical necessity). Though the program created by Amendment 2 contains a patient condition list to obtain eligibility, it also allows doctors to use their professional judgment as to whether or not medical cannabis may assist a patient. This flexibility is notable and something for other states with limited condition lists to consider. Rules governing program operation were released in May of 2019, and state regulators began accepting applications for medical cannabis dispensaries in August of that year.
Share